Green Age Medical Superspecialities Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -72.63%
- Profit Growth -95.42%
- Ebitda -157.64%
- Net Worth 4.46%
- Total Assets 0.46%
About Green Age Medical Superspecialities
Green Age Medical Superspecialities Private Limited (GAMSPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 March 2012 and has a history of 12 years and ten months. Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ishan Porwal, Sapna Porwal, and Lalit Porwal serve as directors at the Company.
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85195MP2012PTC028085
- Company No.
028085
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Mar 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Green Age Medical Superspecialities?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ishan Porwal  | Director | 10-Apr-2017 | Current |
| Sapna Porwal | Director | 10-Apr-2017 | Current |
| Lalit Porwal | Director | 16-Jul-2018 | Current |
Financial Performance of Green Age Medical Superspecialities.
Green Age Medical Superspecialities Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 72.63% decrease. The company also saw a substantial fall in profitability, with a 95.42% decrease in profit. The company's net worth moved up by a moderate rise of 4.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Green Age Medical Superspecialities?
In 2022, Green Age Medical Superspecialities had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Green Age Medical Superspecialities?
Unlock and access historical data on people associated with Green Age Medical Superspecialities, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Green Age Medical Superspecialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Green Age Medical Superspecialities's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
